osimertinib,azd9592,amivantamab-vmjw
janssen,astrazeneca
['tagrisso', 'azd9592', 'rybrevant', '$jnj', '$azn']
re $jnj mariposa, points out that $azn is about to start the curious ostara trial, testing tagrisso + rybrevant prelude to an in-house egfr/cmet mab combo? $azn just presented azd9592 (=metoo rybrevant) at #aacr23 
Journalist at Evaluate Vantage. Interested in: oncology, immunology. Not interested in: what stock you bought today.